Pfizer Inc. (NYSE: PFE) announced today the completion of a global, ex-China, licensing agreement with 3SBio, Inc. (01530.HK) ...

SEDA Experts LLC, a leading expert witness firm providing world-class financial expert witness services, announced today that ...

Pfizer Inc. has completed the previously announced global, ex-China, licensing agreement with 3SBio Inc., which grants Pfizer exclusive rights for the development, manufacturing and commercialization ...

Pfizer is expected to announce its second-quarter results next month, and analysts predict a single-digit drop in the company’s bottom-line figure.

Report found business relationships between telehealth and pharma companies may indirectly lead patients toward certain ...

The collaboration is the first initiated under Flagship's Pioneering Medicines strategic partnership with Pfizer Inc. announced in July 2023. "We are thrilled to be part of the Flagship and Pfizer ...

Nationwide employment law firm Jackson Lewis PC has added Kaha Kvachatadze as a principal in its White Plains office. He ...

“In the Gulf, we are committed to accelerating the availability of global innovations while fostering partnerships with governments, healthcare providers, and key stakeholders,” Serhat ...

Principal Secretary Ouma Oluga and Pfizer Global President for Emerging Markets Nick Lagunowich on Tuesday unveiled the Pfizer Accord in Nairobi.The partnership under the Accord for a Healthier ...

Pfizer will voluntarily pull its sickle cell disease (SCD) drug Oxbryta from all markets worldwide, a major blow to a $5.4 billion acquisition the New York pharma made two years ago.

Article ‘Count’ and ‘Share’ for Pfizer Global Research & Development, France based on listed parameters only. The articles listed below published by authors from Pfizer Global Research ...